Renal Cell Carcinoma

Overview


Plain-Language Overview

Renal Cell Carcinoma is a type of cancer that starts in the kidneys, which are organs responsible for filtering blood and producing urine. This cancer develops when kidney cells grow uncontrollably, forming a tumor that can affect kidney function. It often causes symptoms like blood in the urine, pain in the side or back, and a noticeable lump in the abdomen. Because the kidneys are part of the urinary system, this disease primarily impacts how the body removes waste and balances fluids. If untreated, the cancer can spread to other parts of the body, making it more difficult to treat. Early detection is important for better outcomes. Smoking, obesity, and certain genetic factors increase the risk of developing this cancer.

Clinical Definition

Renal Cell Carcinoma (RCC) is a malignant tumor arising from the renal tubular epithelial cells of the kidney cortex. It is the most common type of kidney cancer in adults and is characterized by uncontrolled proliferation of these epithelial cells, often due to mutations in the VHL tumor suppressor gene leading to dysregulation of hypoxia-inducible factors and increased angiogenesis. RCC typically presents with the classic triad of hematuria, flank pain, and a palpable abdominal mass, although many cases are asymptomatic and discovered incidentally on imaging. The tumor can invade the renal vein and metastasize to lungs, bones, and lymph nodes. Histologically, clear cell carcinoma is the most common subtype, distinguished by cells with clear cytoplasm due to lipid and glycogen content. RCC is clinically significant due to its potential for aggressive behavior and resistance to conventional chemotherapy.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.